New training helps workers with disabilities stay safe from COVID-19

NCT ID NCT06112249

Completed Prevention Sponsor: Temple University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a training program called SAFE for people with intellectual or developmental disabilities who are working or looking for work. The program taught them about COVID-19, how to use protective gear, social distancing, and self-advocacy. 67 young adults took part, and the results showed they learned more about preventing airborne diseases and felt safer at work.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SAFE Employment Training (behavioral intervention)
What this could lead to: If successful, this program could provide a practical, accessible way to teach people with intellectual disabilities how to protect themselves from airborne diseases at work.
What could go wrong: This is a small, completed feasibility study with only 67 participants. The results may not apply to larger or more diverse groups, and the program may not work as well in real-world settings without peer support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder infectious disease intellectual disability COVID-19 prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COMMUNICABLE DISEASES PREVENTION WORKPLACE INTERVENTION

Contacts and locations

Locations

Community Integrated Services

Philadelphia, Pennsylvania, 19123, United States
JEVS

Collingswood, New Jersey, 08108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.